Stephanie Lauren Vanschaick, DPT - Medicare Physical Therapist in Patchogue, NY

Stephanie Lauren Vanschaick, DPT is a medicare enrolled "Physical Therapist" provider in Patchogue, New York. She graduated from medical school in 2018 and has 6 years of diverse experience with area of expertise as Physical Therapy. She is a member of the group practice New York University and her current practice location is 77 Medford Ave, Patchogue, New York. You can reach out to her office (for appointments etc.) via phone at (631) 758-1910.

Stephanie Lauren Vanschaick is licensed to practice in New York (license number 043431) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1083195895.

Contact Information

Stephanie Lauren Vanschaick, DPT
77 Medford Ave,
Patchogue, NY 11772-1281
(631) 758-1910
(631) 758-1984



Healthcare Provider's Profile

Full NameStephanie Lauren Vanschaick
GenderFemale
SpecialityPhysical Therapy
Experience6 Years
Location77 Medford Ave, Patchogue, New York
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Stephanie Lauren Vanschaick graduated from medical school in 2018
  NPI Data:
  • NPI Number: 1083195895
  • Provider Enumeration Date: 08/29/2018
  • Last Update Date: 09/26/2018
  Medicare PECOS Information:
  • PECOS PAC ID: 9931451150
  • Enrollment ID: I20181016001855

Medical Identifiers

Medical identifiers for Stephanie Lauren Vanschaick such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1083195895NPI-NPPES

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
225100000XPhysical Therapist 043431 (New York)Primary

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
New York University13552324224431

News Archive

Research sheds light on cardiovascular risks of e-cigarettes with nicotine

The usage of e-cigarettes containing nicotine has a significant impact on vascular functions claims new study.

Scientists reveal differences between human and murine microglia used in degenerative disease research

The results of a new research showed that many of the genes that are expressed by microglia are different between humans and mice, which are frequently used as animal models in research on Alzheimer's disease and other neurodegenerative disorders.

RNA-based drugs provide many advantages over CRISPR/Cas9 gene editing system

In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites. Now, researchers at University of California, San Diego School of Medicine, Ludwig Cancer Research and Isis Pharmaceuticals demonstrate a commercially feasible way to use RNA to turn the CRISPR-Cas9 system on and off as desired - permanently editing a gene, but only temporarily activating CRISPR-Cas9.

Three pediatric cardiac hospitals to perform live cases with Toshiba's Infinix CF-i system

Vascular interventions performed in pediatrics require imaging equipment specially designed for this setting. During the Pediatric and Adult Interventional Cardiac Symposium (PICS-AICS), July 24-27, 2011 in Boston, three leading pediatric cardiac hospitals will perform live cases with Toshiba America Medical Systems, Inc.'s Infinix™ CF-i bi-plane cardiovascular systems.

Read more Medical News

› Verified 9 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Stephanie Lauren Vanschaick allows following entities to bill medicare on her behalf.
Provider NameSouth Shore Neurologic Associates, Pc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1083782460
PECOS PAC ID: 5092602110
Enrollment ID: O20040303000492

News Archive

Research sheds light on cardiovascular risks of e-cigarettes with nicotine

The usage of e-cigarettes containing nicotine has a significant impact on vascular functions claims new study.

Scientists reveal differences between human and murine microglia used in degenerative disease research

The results of a new research showed that many of the genes that are expressed by microglia are different between humans and mice, which are frequently used as animal models in research on Alzheimer's disease and other neurodegenerative disorders.

RNA-based drugs provide many advantages over CRISPR/Cas9 gene editing system

In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites. Now, researchers at University of California, San Diego School of Medicine, Ludwig Cancer Research and Isis Pharmaceuticals demonstrate a commercially feasible way to use RNA to turn the CRISPR-Cas9 system on and off as desired - permanently editing a gene, but only temporarily activating CRISPR-Cas9.

Three pediatric cardiac hospitals to perform live cases with Toshiba's Infinix CF-i system

Vascular interventions performed in pediatrics require imaging equipment specially designed for this setting. During the Pediatric and Adult Interventional Cardiac Symposium (PICS-AICS), July 24-27, 2011 in Boston, three leading pediatric cardiac hospitals will perform live cases with Toshiba America Medical Systems, Inc.'s Infinix™ CF-i bi-plane cardiovascular systems.

Read more Medical News

› Verified 9 days ago

Provider NameNew York University
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1285826438
PECOS PAC ID: 1355232422
Enrollment ID: O20081202000185

News Archive

Research sheds light on cardiovascular risks of e-cigarettes with nicotine

The usage of e-cigarettes containing nicotine has a significant impact on vascular functions claims new study.

Scientists reveal differences between human and murine microglia used in degenerative disease research

The results of a new research showed that many of the genes that are expressed by microglia are different between humans and mice, which are frequently used as animal models in research on Alzheimer's disease and other neurodegenerative disorders.

RNA-based drugs provide many advantages over CRISPR/Cas9 gene editing system

In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites. Now, researchers at University of California, San Diego School of Medicine, Ludwig Cancer Research and Isis Pharmaceuticals demonstrate a commercially feasible way to use RNA to turn the CRISPR-Cas9 system on and off as desired - permanently editing a gene, but only temporarily activating CRISPR-Cas9.

Three pediatric cardiac hospitals to perform live cases with Toshiba's Infinix CF-i system

Vascular interventions performed in pediatrics require imaging equipment specially designed for this setting. During the Pediatric and Adult Interventional Cardiac Symposium (PICS-AICS), July 24-27, 2011 in Boston, three leading pediatric cardiac hospitals will perform live cases with Toshiba America Medical Systems, Inc.'s Infinix™ CF-i bi-plane cardiovascular systems.

Read more Medical News

› Verified 9 days ago

Provider NameNew York University
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1285826438
PECOS PAC ID: 1355232422
Enrollment ID: O20090822000026

News Archive

Research sheds light on cardiovascular risks of e-cigarettes with nicotine

The usage of e-cigarettes containing nicotine has a significant impact on vascular functions claims new study.

Scientists reveal differences between human and murine microglia used in degenerative disease research

The results of a new research showed that many of the genes that are expressed by microglia are different between humans and mice, which are frequently used as animal models in research on Alzheimer's disease and other neurodegenerative disorders.

RNA-based drugs provide many advantages over CRISPR/Cas9 gene editing system

In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites. Now, researchers at University of California, San Diego School of Medicine, Ludwig Cancer Research and Isis Pharmaceuticals demonstrate a commercially feasible way to use RNA to turn the CRISPR-Cas9 system on and off as desired - permanently editing a gene, but only temporarily activating CRISPR-Cas9.

Three pediatric cardiac hospitals to perform live cases with Toshiba's Infinix CF-i system

Vascular interventions performed in pediatrics require imaging equipment specially designed for this setting. During the Pediatric and Adult Interventional Cardiac Symposium (PICS-AICS), July 24-27, 2011 in Boston, three leading pediatric cardiac hospitals will perform live cases with Toshiba America Medical Systems, Inc.'s Infinix™ CF-i bi-plane cardiovascular systems.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Stephanie Lauren Vanschaick is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Stephanie Lauren Vanschaick, DPT
712 Main St,
Islip, NY 11751-3620

Ph: (631) 666-3951
Stephanie Lauren Vanschaick, DPT
77 Medford Ave,
Patchogue, NY 11772-1281

Ph: (631) 758-1910

News Archive

Research sheds light on cardiovascular risks of e-cigarettes with nicotine

The usage of e-cigarettes containing nicotine has a significant impact on vascular functions claims new study.

Scientists reveal differences between human and murine microglia used in degenerative disease research

The results of a new research showed that many of the genes that are expressed by microglia are different between humans and mice, which are frequently used as animal models in research on Alzheimer's disease and other neurodegenerative disorders.

RNA-based drugs provide many advantages over CRISPR/Cas9 gene editing system

In just the past few years, researchers have found a way to use a naturally occurring bacterial system known as CRISPR/Cas9 to inactivate or correct specific genes in any organism. CRISPR/Cas9 gene editing activity runs continuously, though, leading to risk of additional editing at unwanted sites. Now, researchers at University of California, San Diego School of Medicine, Ludwig Cancer Research and Isis Pharmaceuticals demonstrate a commercially feasible way to use RNA to turn the CRISPR-Cas9 system on and off as desired - permanently editing a gene, but only temporarily activating CRISPR-Cas9.

Three pediatric cardiac hospitals to perform live cases with Toshiba's Infinix CF-i system

Vascular interventions performed in pediatrics require imaging equipment specially designed for this setting. During the Pediatric and Adult Interventional Cardiac Symposium (PICS-AICS), July 24-27, 2011 in Boston, three leading pediatric cardiac hospitals will perform live cases with Toshiba America Medical Systems, Inc.'s Infinix™ CF-i bi-plane cardiovascular systems.

Read more News

› Verified 9 days ago


Physical Therapist in Patchogue, NY

Ronald Amaya Lopez, DPT
Physical Therapist
Medicare: Medicare Enrolled
Practice Location: 322 W Main St, Patchogue, NY 11772
Phone: 631-228-4977    
Sungguk Bae,
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 21 Cleveland St, Patchogue, NY 11772
Phone: 631-569-9373    
Nicole Marie Divirgilio, PT
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 77 Route 112 Ste F, Patchogue, NY 11772
Phone: 631-207-2370    
John Lowe Wilson, PT
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 25 Theresa Ct, Patchogue, NY 11772
Phone: 631-730-3326    
Danielle M Bousquet,
Physical Therapist
Medicare: Not Enrolled in Medicare
Practice Location: 77 Medford Ave, Patchogue, NY 11772
Phone: 631-758-1910    
Kathleen Alyssa Bailey, DPT
Physical Therapist
Medicare: Accepting Medicare Assignments
Practice Location: 322 W Main St, Patchogue, NY 11772
Phone: 631-228-4977    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.